Disruption of these pathways have been previously linked to CHH (olfactory dysfunction (anosmia) and hypogonadotropic hypogonadism in Kallmann Syndrome; TAC3R variants in CHH61) but not to ovary insufficiency phenotypes. This evidence concerns the gene TACR3 and hypogonadotropic hypogonadism.